Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (121-130 of 291) with videos related to

Pageof 30
Sort By:
The Journal of Infectious Diseases|October 23, 2012
1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansMatthew S Miller, Tshidi Tsibane, Florian Krammer, et al.
Journal of Virology|January 7, 2011
Budding capability of the influenza virus neuraminidase can be modulated by tetherinMark A Yondola, Fiona Fernandes, Alan Belicha-Villanueva, et al.
Glycoconjugate Journal|April 1, 2006
Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North AmericaLaurel Glaser, Dmitriy Zamarin, Helen M Acland, et al.
The Journal of Experimental Medicine|August 20, 2014
Long-term survival of influenza virus infected club cells drives immunopathologyNicholas S Heaton, Ryan A Langlois, David Sachs, et al.
Plos One|November 13, 2012
Identification of small molecules with type I interferon inducing properties by high-throughput screeningLuis Martínez-Gil, Juan Ayllon, Mila Brum Ortigoza, et al.
Journal of Virology|November 19, 2010
A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivoGina M Conenello, Jennifer R Tisoncik, Elizabeth Rosenzweig, et al.
Journal of Virology|December 19, 2022
Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype ImmunityPhilip Meade, Shirin Strohmeier, Maria Carolina Bermúdez-González, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2023
Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivoJulia E Edgar, Stephanie Trezise, Robert M Anthony, et al.
Plos Pathogens|June 23, 2011
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor proteinZsuzsanna T Varga, Irene Ramos, Rong Hai, et al.
Journal of Virology|November 20, 2002
Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domainsXiuyan Wang, Christopher F Basler, Bryan R G Williams, et al.
Pageof 30

Showing results (121-130 of 291) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|October 23, 2012
1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansMatthew S Miller, Tshidi Tsibane, Florian Krammer, et al.
Journal of Virology|January 7, 2011
Budding capability of the influenza virus neuraminidase can be modulated by tetherinMark A Yondola, Fiona Fernandes, Alan Belicha-Villanueva, et al.
Glycoconjugate Journal|April 1, 2006
Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North AmericaLaurel Glaser, Dmitriy Zamarin, Helen M Acland, et al.
The Journal of Experimental Medicine|August 20, 2014
Long-term survival of influenza virus infected club cells drives immunopathologyNicholas S Heaton, Ryan A Langlois, David Sachs, et al.
Plos One|November 13, 2012
Identification of small molecules with type I interferon inducing properties by high-throughput screeningLuis Martínez-Gil, Juan Ayllon, Mila Brum Ortigoza, et al.
Journal of Virology|November 19, 2010
A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivoGina M Conenello, Jennifer R Tisoncik, Elizabeth Rosenzweig, et al.
Journal of Virology|December 19, 2022
Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype ImmunityPhilip Meade, Shirin Strohmeier, Maria Carolina Bermúdez-González, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2023
Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivoJulia E Edgar, Stephanie Trezise, Robert M Anthony, et al.
Plos Pathogens|June 23, 2011
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor proteinZsuzsanna T Varga, Irene Ramos, Rong Hai, et al.
Journal of Virology|November 20, 2002
Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domainsXiuyan Wang, Christopher F Basler, Bryan R G Williams, et al.
Pageof 30